CEO Waleed Hassanein and CFO Gerardo Hernandez-Omana provided updates on the company’s strategy, clinical trial planning, and ...

TransMedics continues to reinvent the organ transplant industry, but the market insists the stock is "overvalued" now.

TransMedics' stock tanked after the company reported third-quarter results. Third-quarter sales rose 64% year over year, but fell slightly compared to the previous quarter. The pullback coincided with ...

ANDOVER, Mass., Feb. 9, 2026 /PRNewswire/ -- TransMedics Group, Inc. ("TransMedics") (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with ...

One such corporation to consider is TransMedics Group (NASDAQ: TMDX), which is helping revolutionize the organ transplant ...

TransMedics markets an organ care system that pumps warm blood through hearts, lungs, and livers after they've been donated for transplant recipients. TransMedics Group stock rose over 100% in 2024, ...

Shares of leading organ transplant technology company TransMedics (NASDAQ: TMDX) rose 15% as of noon ET on Thursday, according to data provided by S&P Global Market Intelligence. TransMedics reported ...

The traditional method for preserving organs during transport is placing organs on ice in a cooler. However, this method has several limitations. The organs are viable only for a few hours due to lack ...

From the beginning of 2024 through Aug. 23, shares of TransMedics (NASDAQ: TMDX) stock soared by 123% -- but the good times didn't last. A third-quarter earnings miss sent shares of the ...

TransMedics Group (NASDAQ: TMDX) was a top-performing stock that more than doubled in value during the months between the end of 2023 and late August. Unfortunately, shares of the healthcare stock ...